Sclerosis News and Research

RSS

Miniature heart model holds the key to saving lives and enhancing patient outcomes

Discovery led by Prof. Yaakov Nahmias from the Hebrew University marks a new era in cardiovascular research, multi-chambered, self-paced miniature heart model, holding the key to saving lives and enhancing patient outcomes.

7 Aug 2023

EULAR releases new recommendations for non-pharmacological management of SLE and SSc

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. Systemic sclerosis (SSc) or scleroderma is another rheumatic autoimmune disease that affects blood vessels, skin, and visceral organs.

7 Aug 2023

Machine learning in neurodegenerative disease research: a growing trend

Scientists explore the utility of machine learning methods in the field of neurodegenerative disease diagnosis, prognosis, and treatment effect prediction.

4 Aug 2023

Reversing β-cell failure: A promising approach for type 2 diabetes treatment

Researchers examined current evidence on the reasons and implications of pancreatic beta-cell failure.

3 Aug 2023

Study finds α5 integrin as a potential therapeutic target in amyotrophic lateral sclerosis

Researchers examined the therapeutic effects of targeting integrins for treating Amyotrophic lateral sclerosis (ALS).

3 Aug 2023

Frequent headaches linked to bullying, suicidal tendencies in teens

Teens who have been bullied by their peers, or who have considered or attempted suicide, may be more likely to have more frequent headaches than teens who have not experienced any of these problems, according to a study published in the August 2, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Aug 2023

Study finds disparities in access to memory care clinics

Black people and people living in less affluent neighborhoods - areas with higher poverty levels and fewer educational and employment opportunities - may be less likely to be seen at a memory care clinic compared to white people and people living in neighborhoods with fewer disadvantages, according to new research published in the August 2, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Aug 2023

Can vitamin D have positive effects on reducing cortical pathology, oxidative stress, and neurofilament light chain serum levels?

Researchers use an established murine model of cortical inflammatory demyelination to investigate the effects of vitamin D.

2 Aug 2023

Study offers deeper understanding of regulatory T cells yielding therapeutic benefits

Decades of research have left knowledge gaps about cells that regulate the immune system: Purdue and NIH.

1 Aug 2023

Research reveals surprising genetic overlap between neurological and psychiatric disorders

Researchers compared the shared genetic risk and biological foundations of neurological and mental illnesses.

1 Aug 2023

Monoclonal antibody shows promise in slowing progression of ALS

New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal neurodegenerative disease.

31 Jul 2023

Researchers study the impact of teleneurology program on timeliness of access to neurological care

Accessing neurologic care often presents physical, geographical and financial challenges to patients, many of whom face chronic and disabling conditions.

27 Jul 2023

People with Alzheimer's risk gene may lose ability to detect odors earlier

People who carry the gene variant associated with the strongest risk for Alzheimer's disease may lose their ability to detect odors earlier than people who do not carry the gene variant, which may be an early sign of future memory and thinking problems, according to a study published in the July 26, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

26 Jul 2023

Experts weigh benefits and risks of new Alzheimer's disease therapies

New therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease.

26 Jul 2023

Drug interferon proven effective to reduce the spread of COVID-19

Results of an innovative clinical trial led by Perth researchers have shown that the drug interferon could help reduce the spread of COVID-19 from a positive person to their household contacts, with the study helping to inform treatment options for a future pandemic.

26 Jul 2023

New AI-based system aims to facilitate the rehabilitation process for stroke patients

Statistics indicate that globally 1 in 4 adults over the age of 25 will have a stroke in their lifetime. One of the most serious consequences of this disease is disability.

24 Jul 2023

Extracellular vesicles may drive fibrosis in scleroderma

Extracellular vesicles, responsible for cell-to-cell communication, might be a driver of fibrosis in systemic sclerosis, according to a recent paper in Arthritis and Rheumatology.

21 Jul 2023

Hundreds of proteins and mRNA molecules mislocated in ALS nerve cells

Researchers at the Francis Crick Institute and UCL have shown that hundreds of proteins and mRNA molecules are found in the wrong place in nerve cells affected by Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS).

21 Jul 2023

Insights into the pathophysiological mechanisms governing neuropsychiatric symptoms of multiple sclerosis

Researchers pursued insights into the pathophysiological mechanisms governing neuropsychiatric symptoms of MS.

21 Jul 2023

Early treatment for multiple sclerosis linked to lower disability risk

People who start taking medication soon after the first signs of multiple sclerosis (MS) may have a lower risk of disability later, according to a study published in the July 19, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Jul 2023

Sclerosis News and Research

Miniature heart model holds the key to saving lives and enhancing patient outcomes

EULAR releases new recommendations for non-pharmacological management of SLE and SSc

Machine learning in neurodegenerative disease research: a growing trend

Reversing β-cell failure: A promising approach for type 2 diabetes treatment

Study finds α5 integrin as a potential therapeutic target in amyotrophic lateral sclerosis

Frequent headaches linked to bullying, suicidal tendencies in teens

Study finds disparities in access to memory care clinics

Can vitamin D have positive effects on reducing cortical pathology, oxidative stress, and neurofilament light chain serum levels?

Study offers deeper understanding of regulatory T cells yielding therapeutic benefits

Research reveals surprising genetic overlap between neurological and psychiatric disorders

Monoclonal antibody shows promise in slowing progression of ALS

Researchers study the impact of teleneurology program on timeliness of access to neurological care

People with Alzheimer's risk gene may lose ability to detect odors earlier

Experts weigh benefits and risks of new Alzheimer's disease therapies

Drug interferon proven effective to reduce the spread of COVID-19

New AI-based system aims to facilitate the rehabilitation process for stroke patients

Extracellular vesicles may drive fibrosis in scleroderma

Hundreds of proteins and mRNA molecules mislocated in ALS nerve cells

Insights into the pathophysiological mechanisms governing neuropsychiatric symptoms of multiple sclerosis

Early treatment for multiple sclerosis linked to lower disability risk

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News